Download Now | This week's Fierce Biotech is brought to you by Lonza.
Trouble viewing? Click here. |
In this e-book, we delve into the critical aspects of drug development, providing valuable insights and strategies to mitigate risks at every stage.
| e-book | | Tools to De-risk Pharmaceutical Development | | |
|
|
|
| Drug development is a complex and challenging journey, often marked by high risks, substantial investments, and prolonged timelines. In this e-book, we delve into the critical aspects of drug development, providing valuable insights and strategies to mitigate risks at every stage. Learn about three powerful approaches solid form screening, physiologically based pharmacokinetic (PBPK) modeling, and retrosynthetic analysis and their pivotal roles in de-risking drug development. Get your copy |
|
|
| Explore Three Proven Approaches |
|
|
| Solid Form Screening | | Our solid form services are designed for flexibility and can be readily accessed alone or as part of an integrated drug substance and/or drug product development program. |
|
|
|
| PBPK Modeling | | Using established modeling software, linked with an expansive set of in-vitro testing, we can identify absorption risks and select technologies to meet target bioperformance. |
|
|
|
|
| Route Scouting | | Develop and deploy Lonza IP-enabled route planning informatics and automation technologies to accelerate route selection and process development. |
|
|
|
| Lonza Small Molecules | | From candidate compound to lead form to final drug product, we are committed to empowering drug developers with the knowledge and tools needed to achieve greater success in bringing new drugs to market efficiently, safely and reliably. | | |
|
|
| © 2024 Lonza. All Rights Reserved.
Muenchensteinerstrasse 38
Basel 4002
Switzerland |
|
|
| If you no longer wish to receive communications from Lonza, please opt out here.
Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.
You are currently subscribed as [email protected].
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.
Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017 |
